In malignant melanoma, a significantly downregulated expression of RBM3 was observed in metastases compared to primary melanoma [12], which is in line with previous in vitro data demonstrating a significant downregulation of RBM3 expression in metastatic compared to primary melanoma cells [15]. This evidence concerns the gene RBM3 and melanoma.